glutathione schizophrenia deficiency in the early postnatal developmental period as a neurodevelopmental animal model of | Pharmacological Reports FAB: Antioxidants in brain linked
FAB: Antioxidants in brain linked to improved psychosis treatment glutathione levels in schizophrenia Factors that contribute to the production of ROS and subsequent Glutathione antioxidant pathways in patients Full article: Targeting of NMDA receptors in new treatments for schizophrenia Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry Translational Psychiatry Antioxidants in brain linked to improved psychosis treatment Neuroscience News
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




